Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin R L, Hoffman S L
Malaria Program, Naval Medical Research Institute, Bethesda, MD 20889.
Science. 1991 May 3;252(5006):715-8. doi: 10.1126/science.1827210.
The circumsporozoite (CS) protein has been the target for development of malaria sporozoite vaccines for a decade. However, immunization with subunit vaccines based on the CS protein has never given the complete protection found after immunization with irradiated sporozoites. BALB/c mice immunized with irradiated Plasmodium yoelii sporozoites produced antibodies and cytotoxic T cells against a 140-kilodalton protein, sporozoite surface protein 2 (SSP2). Mice immunized with P815 cells that had been transfected with either SSP2 or CS genes were partially protected, and those immunized with a mixture of SSP2 and CS transfectants were completely protected against malaria. These studies emphasize the importance of vaccine delivery systems in achieving protection and define a multi-antigen sporozoite vaccine.
十年来,环子孢子(CS)蛋白一直是疟疾子孢子疫苗研发的靶点。然而,基于CS蛋白的亚单位疫苗免疫从未像用辐照子孢子免疫后那样提供完全的保护。用辐照的约氏疟原虫子孢子免疫的BALB/c小鼠产生了针对一种140千道尔顿蛋白——子孢子表面蛋白2(SSP2)的抗体和细胞毒性T细胞。用转染了SSP2或CS基因的P815细胞免疫的小鼠受到了部分保护,而用SSP2和CS转染子混合物免疫的小鼠则完全受到了疟疾保护。这些研究强调了疫苗递送系统在实现保护方面的重要性,并确定了一种多抗原子孢子疫苗。